Tenofovir News and Research

RSS
UC researcher receives $443,000 NIH grant to study antiviral drugs

UC researcher receives $443,000 NIH grant to study antiviral drugs

Cabotegravir highly effective in preventing HIV among women

Cabotegravir highly effective in preventing HIV among women

HIV drugs cause immune-system changes that can improve resistance to viral infections

HIV drugs cause immune-system changes that can improve resistance to viral infections

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Researchers launch study to evaluate safety of HIV prevention methods in breastfeeding women

Researchers launch study to evaluate safety of HIV prevention methods in breastfeeding women

Study identifies three potential drugs to eradicate parasitic worms

Study identifies three potential drugs to eradicate parasitic worms

NIH study: Long-acting form of HIV prevention drug more effective than daily oral pill

NIH study: Long-acting form of HIV prevention drug more effective than daily oral pill

Newly identified molecules can help develop COVID-19 therapeutics

Newly identified molecules can help develop COVID-19 therapeutics

Newer antiretroviral drugs may be the safest, most effective HIV treatment during pregnancy

Newer antiretroviral drugs may be the safest, most effective HIV treatment during pregnancy

PrEP drug levels found to lower among pregnant African adolescent girls and young women

PrEP drug levels found to lower among pregnant African adolescent girls and young women

Study to evaluate safety of PrEP and dapivirine ring in pregnant women

Study to evaluate safety of PrEP and dapivirine ring in pregnant women

New clinical trial to examine the safety of dapivirine vaginal ring and PrEP in pregnant women

New clinical trial to examine the safety of dapivirine vaginal ring and PrEP in pregnant women

Research leverages emergency room visits to connect at risk populations to preventive services

Research leverages emergency room visits to connect at risk populations to preventive services

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

Tailored adherence strategies needed to engage young African women in consistent PrEP use

Tailored adherence strategies needed to engage young African women in consistent PrEP use

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

Antiviral treatment improves survival for kidney transplant recipients infected with HBV or HCV

Antiviral treatment improves survival for kidney transplant recipients infected with HBV or HCV

New clinical trial aims to examine safety and use of two HIV prevention tools

New clinical trial aims to examine safety and use of two HIV prevention tools

MTN launches new study to empower teen girls with choices in HIV prevention

MTN launches new study to empower teen girls with choices in HIV prevention